World Journal of Molecular Medicine

About Journal

The World Journal of Molecular Medicine (ISSN: 3065-5196) is a peer-reviewed open-access journal committed to advancing scientific research in molecular biology, biomedical sciences, and translational medicine. Our mission is to provide a dynamic platform for researchers, clinicians, and academicians to publish original research, reviews, and analyses that explore the molecular and cellular basis of diseases, their progression, and therapeutic approaches. The journal serves as a critical resource for professionals who are investigating molecular-level interactions and their implications in diagnostics, treatment, and disease prevention.

In recent decades, molecular medicine has transformed our understanding of how diseases develop at the genetic, protein, and cellular levels. This field bridges basic laboratory science with clinical applications, allowing for a deeper understanding of complex pathophysiological mechanisms. The World Journal of Molecular Medicine aims to support this evolution by encouraging the exchange of knowledge that can contribute to the design of personalized medicine, drug discovery, and regenerative therapies.

The journal’s scope includes a wide array of topics in the molecular sciences that contribute directly or indirectly to human health. Research that enhances our understanding of molecular pathways, genetic mutations, signal transduction, cellular interactions, and molecular diagnostics is highly encouraged.

Key Research Domains Covered

The journal offers a home for interdisciplinary research that connects molecular science with clinical outcomes. The following research areas reflect the core focus of the journal:

Molecular Pathology and Biomarkers

We welcome studies that explore the identification and functional analysis of biomarkers that indicate disease progression or treatment response. This includes genomic, proteomic, and metabolomic profiling techniques.

Gene Expression and Regulation

Articles discussing transcriptional and post-transcriptional gene regulation, non-coding RNAs, RNA editing, gene silencing, and epigenetic modifications will find a place within our journal’s focus.

Molecular Oncology

We invite submissions addressing the genetic and molecular alterations that drive various cancers, molecular tumor classification, signal transduction pathways, oncogenes, tumor suppressor genes, and molecular approaches to cancer therapy.

Immunology and Molecular Immunopathology

The journal supports research on immune cell signaling, cytokine networks, immune tolerance, molecular mechanisms of autoimmune diseases, and molecular approaches in vaccine development.

Pharmacogenomics and Drug Development

Studies exploring gene-drug interactions, individual variability in drug responses, and molecular pharmacology are of high interest. Content related to high-throughput drug screening, target validation, and preclinical models is particularly encouraged.

Molecular Genetics and Inherited Disorders

We publish research focusing on the identification of mutations responsible for hereditary diseases, gene therapy strategies, molecular diagnostics, and inheritance patterns affecting clinical treatment strategies.

Cell Signaling and Signal Transduction

This includes research on intracellular signaling cascades, receptor interactions, and pathway dysregulation in diseases such as diabetes, neurodegeneration, and cancer.

Neurobiology at the Molecular Level

Papers that investigate molecular aspects of neural development, neurotransmitter signaling, synaptic plasticity, and the genetic underpinnings of neurological disorders are welcome.

Infectious Diseases and Host-Pathogen Interactions

We encourage molecular studies on microbial pathogenesis, viral replication, immune evasion strategies, and the development of molecular diagnostic tools for infectious diseases.

Aims of the Journal

The primary objective of the World Journal of Molecular Medicine is to disseminate high-quality scientific information that deepens the molecular understanding of disease mechanisms. We aim to provide a scholarly venue where rigorous and innovative research can influence the future of biomedical science and clinical practice. We seek to promote interdisciplinary dialogue and to stimulate the translation of fundamental discoveries into therapeutic innovations.

Our audience includes molecular biologists, clinicians, biochemists, geneticists, pharmacologists, microbiologists, and academic researchers from around the world. The journal serves as a conduit for transformative research that has the potential to improve diagnostic strategies, therapeutic interventions, and overall patient care.

We are particularly interested in publishing research that demonstrates potential clinical relevance or translational value, even when originating from basic molecular research. This is in alignment with the global shift toward precision medicine and targeted therapeutic interventions based on molecular data.

Scope of Submissions

Authors are invited to submit manuscripts in the following categories:

Original Research Articles: Detailed experimental studies that provide new insights into molecular and cellular processes related to health and disease.

Review Articles: Thorough analyses of current topics, including recent advancements, gaps in research, and emerging molecular trends.

Mini-Reviews and Updates: Concise summaries focused on highly specific areas or recent developments in molecular medicine.

Methodological Papers: Descriptions of new techniques or improved molecular protocols that can enhance laboratory or diagnostic workflows.

Translational Reports: Research that bridges the gap between bench science and clinical application.

Case-Based Molecular Insights: Case studies with a strong molecular or genetic component that provide learning opportunities for diagnostic or treatment implications.

Commitment to Scientific Integrity

All manuscripts submitted to the World Journal of Molecular Medicine undergo a comprehensive peer-review process. Our editorial team includes experts with specialized backgrounds who ensure that published content meets the highest standards of accuracy, reproducibility, and scientific integrity.

We value transparency and ethical publishing practices. All research involving human or animal subjects must include appropriate ethical approval statements and comply with international research standards. Authors are required to disclose any potential conflicts of interest and sources of funding.

Open Access and Article Processing Policy

The journal operates under an open-access model, ensuring that all articles are freely available to readers worldwide upon publication. To support the editorial and publication process, an article processing charge (APC) applies to all accepted manuscripts. Authors will be informed about the APC following the acceptance of their submission. There are no fees for submission or peer review.